Hardy ST, Jaeger BC, Foti K, Ghazi L, Wozniak G, Muntner P. Trends in blood pressure control among US adults with hypertension, 2013–2014 to 2021–2023. Am J Hypertens. 2025;38(2):120–8. https://doi.org/10.1093/ajh/hpae141.

Article  PubMed  Google Scholar 

Abbas A, Hannan J, Stolp H, Coronado F, Sperling LS. Commitment to hypertension control during the COVID-19 pandemic: million hearts initiative exemplars. Prev Chronic Dis. 2022;19:E47. https://doi.org/10.5888/pcd19.210439.

Article  PubMed  PubMed Central  Google Scholar 

Abdalla M, Bolen SD, Brettler J, Egan BM, Ferdinand KC, Ford CD, et al. Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American heart association and American medical association. Hypertension. 2023;80(10):e143–57. https://doi.org/10.1161/hyp.0000000000000232.

Article  CAS  PubMed  Google Scholar 

Colvin CL, Kalejaiye A, Ogedegbe G, Commodore-Mensah Y. Advancing equity in blood pressure control: a response to the surgeon general’s call-to-action. Am J Hypertens. 2022;35(3):217–24. https://doi.org/10.1093/ajh/hpab187.

Article  PubMed  PubMed Central  Google Scholar 

Smith PA, Overton K, Rakotz M, Wozniak G, Sanchez E. BP™: a national initiative to improve blood pressure control. Hypertension. 2023;80(12):2523–32. https://doi.org/10.1161/hypertensionaha.123.20389.

Article  CAS  PubMed  Google Scholar 

Lu Y, Liu Y, Dhingra LS, Massey D, Caraballo C, Mahajan S, et al. National trends in racial and ethnic disparities in antihypertensive medication use and blood pressure control among adults with hypertension, 2011–2018. Hypertension. 2022;79(1):207–17. https://doi.org/10.1161/hypertensionaha.121.18381.

Article  CAS  PubMed  Google Scholar 

Jackson SL, Nair PR, Chang A, Schieb L, Loustalot F, Wall HK, et al. Antihypertensive and statin medication adherence among medicare beneficiaries. Am J Prev Med. 2022;63(3):313–23. https://doi.org/10.1016/j.amepre.2022.02.019.

Article  PubMed  PubMed Central  Google Scholar 

Dean YE, Motawea KR, Shebl MA, Elawady SS, Nuhu K, Abuzuaiter B, et al. Adherence to antihypertensives in the United States: a comparative meta-analysis of 23 million patients. J Clin Hypertens (Greenwich). 2024;26(4):303–13. https://doi.org/10.1111/jch.14788.

Article  PubMed  Google Scholar 

Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Lancet. 2022;399(10333):1401–10. https://doi.org/10.1016/s0140-6736(22)00455-x.

Article  CAS  PubMed  Google Scholar 

Mahfoud F, Mancia G, Schmieder RE, Ruilope L, Narkiewicz K, Schlaich M, et al. Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY registry DEFINE. Hypertension. 2023;80(8):1759–70. https://doi.org/10.1161/hypertensionaha.123.21283.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Zhao F, Ye R, Zhang X, Peng Y, Chen X, et al. Medication changes after renal denervation: current evidence and patient perspectives. J Am Heart Assoc. 2024;13(24):e037187. https://doi.org/10.1161/jaha.124.037187.

Article  PubMed  PubMed Central  Google Scholar 

Centers for medicare & medicaid services: renal denervation for uncontrolled hypertension: national coverage analysis decision memo. 2025. https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=318. Accessed.

Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108):2160–70. https://doi.org/10.1016/s0140-6736(17)32281-x.

Article  PubMed  Google Scholar 

Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346–55. https://doi.org/10.1016/s0140-6736(18)30951-6.

Article  PubMed  Google Scholar 

Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234):1444–51. https://doi.org/10.1016/s0140-6736(20)30554-7.

Article  PubMed  Google Scholar 

Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J Am Coll Cardiol. 2023;82(19):1809–23. https://doi.org/10.1016/j.jacc.2023.08.045.

Article  CAS  PubMed  Google Scholar 

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137):2335–45. https://doi.org/10.1016/s0140-6736(18)31082-1.

Article  PubMed  Google Scholar 

Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, et al. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA. 2023;329(8):651–61. https://doi.org/10.1001/jama.2023.0713.

Article  PubMed  PubMed Central  Google Scholar 

Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293):2476–86. https://doi.org/10.1016/s0140-6736(21)00788-1.

Article  CAS  PubMed  Google Scholar 

Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, et al. Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation. 2024;149(24):1875–84. https://doi.org/10.1161/circulationaha.124.069291.

Article  CAS  PubMed  Google Scholar 

Fisher NDL, Kirtane AJ. Renal denervation for hypertension. Nat Rev Cardiol. 2025. https://doi.org/10.1038/s41569-024-01104-z.

Article  PubMed  Google Scholar 

Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014;64(7):635–43. https://doi.org/10.1016/j.jacc.2014.03.059.

Article  PubMed  Google Scholar 

García-Touchard A, Maranillo E, Mompeo B, Sañudo JR. Microdissection of the human renal nervous system: implications for performing renal denervation procedures. Hypertension. 2020;76(4):1240–6. https://doi.org/10.1161/hypertensionaha.120.15106.

Article  PubMed  Google Scholar 

Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Jander D, et al. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol. 2015;66(16):1766–75. https://doi.org/10.1016/j.jacc.2015.08.018.

Article  PubMed  Google Scholar 

Fengler K, Rommel KP, Blazek S, Besler C, Hartung P, von Roeder M, et al. A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN). Circulation. 2019;139(5):590–600. https://doi.org/10.1161/circulationaha.118.037654.

Article  PubMed  Google Scholar 

Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393–401. https://doi.org/10.1056/NEJMoa1402670.

Article  CAS  PubMed  Google Scholar 

Kirtane AJ, Sharp ASP, Mahfoud F, Fisher NDL, Schmieder RE, Daemen J, et al. Patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials. JAMA Cardiol. 2023;8(5):464–73. https://doi.org/10.1001/jamacardio.2023.0338.

Article  PubMed  PubMed Central  Google Scholar 

Medtronic. Symplicity Spyral™ multi-electrode renal denervation catheter, RDN016, clinical study summary. 2023.

Pathak A, Rudolph UM, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, et al. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention. 2023;19(7):602–11. https://doi.org/10.4244/eij-d-23-00088.

Article  PubMed  PubMed Central